#Stem_Cell_Therapy
LightNews LightNews
newsen.bsky.social
Gallant's Groundbreaking Stem Cell Therapy Gains FDA Safety Approval for Cats with Chronic Gingivostomatitis#USA#San_Diego#Stem_Cell_Therapy#Gallant#FCGS
Gallant's Groundbreaking Stem Cell Therapy Gains FDA Safety Approval for Cats with Chronic Gingivostomatitis
Gallant's first ready-to-use stem cell therapy for cats, targeting refractory FCGS, earns FDA's safety milestone. A remarkable step forward in veterinary medicine!
third-news.com
November 10, 2025 at 2:25 PM
newsen.bsky.social
Joseph Spine Institute Unveils State-of-the-Art Regenerative Spine Medicine Center with Advanced Stem Cell Therapy#United_States#Tampa#Stem_Cell_Therapy#Joseph_Spine#Dr._Samuel_Joseph
Joseph Spine Institute Unveils State-of-the-Art Regenerative Spine Medicine Center with Advanced Stem Cell Therapy
The Joseph Spine Institute has launched a cutting-edge regenerative spine medicine center, providing innovative stem cell treatments for chronic spine conditions.
third-news.com
April 10, 2025 at 8:12 AM
newsen.bsky.social
Evaluation of Efficacy of Canine Model for Dilated Cardiomyopathy Using IHJ-301#Japan#Kyoto#Stem_Cell_Therapy#iHeart_Japan#Dilated_Cardiomyopathy
Evaluation of Efficacy of Canine Model for Dilated Cardiomyopathy Using IHJ-301
iHeart Japan has published its research on the efficacy of IHJ-301 in treating canine dilated cardiomyopathy, a breakthrough in regenerative medicine.
third-news.com
August 19, 2026 at 2:41 AM
newsen.bsky.social
Future Growth of the Stem Cell Therapy Market to Reach $3.65 Billion by 2035#USA#Delray_Beach#regenerative_medicine#Stem_Cell_Therapy#iPSC_Technology
Future Growth of the Stem Cell Therapy Market to Reach $3.65 Billion by 2035
The stem cell therapy market is on an exponential rise, projected to grow from $0.48 billion in 2026 to $3.65 billion by 2035, driven by innovation and demand.
third-news.com
June 15, 2026 at 2:33 PM
newsen.bsky.social
Gallant's Promising Stem Cell Therapy for Feline Osteoarthritis Approved for Conditional FDA Pathway#United_States#San_Diego#Stem_Cell_Therapy#Gallant#Feline_Osteoarthritis
Gallant's Promising Stem Cell Therapy for Feline Osteoarthritis Approved for Conditional FDA Pathway
Gallant's groundbreaking study on stem cell treatment for feline osteoarthritis shows promising results, paving the way for FDA conditional approval.
third-news.com
April 15, 2026 at 12:56 PM
newsen.bsky.social
The Growing Animal Regenerative Therapies Market Set to Hit USD 870 Million by 2032#India#Noida#Stem_Cell_Therapy#Animal_Regenerative_Therapies#Veterinary_Biotechnology
The Growing Animal Regenerative Therapies Market Set to Hit USD 870 Million by 2032
The Animal Regenerative Therapies Market is on the rise, projected to reach USD 870 million by 2032, fueled by significant advancements in veterinary biotechnology.
third-news.com
March 19, 2026 at 7:48 AM
newsen.bsky.social
Exciting New Research on Stem Cell Therapies for Diabetic Foot Ulcers Published by Longevity Medical Institute#Mexico#Los_Cabos#Stem_Cell_Therapy#Longevity_Medical_Institute#Diabetic_Ulcers
Exciting New Research on Stem Cell Therapies for Diabetic Foot Ulcers Published by Longevity Medical Institute
Longevity Medical Institute's recent study unveils promising findings on stem cell therapies for diabetic foot ulcers, enhancing chronic wound care.
third-news.com
March 11, 2026 at 2:25 PM
newsen.bsky.social
Veterinary Experts Embrace Stem Cell Therapy for Inflammatory Pet Conditions: Survey Insights#United_States#San_Diego#Veterinary_Medicine#Stem_Cell_Therapy#Gallant
Veterinary Experts Embrace Stem Cell Therapy for Inflammatory Pet Conditions: Survey Insights
A recent survey reveals that a majority of veterinary professionals view stem cell therapy as a future standard for treating inflammatory diseases in pets. Learn more about their optimism and the changing landscape of veterinary medicine.
third-news.com
March 2, 2026 at 2:53 PM
newsen.bsky.social
Innovative Veterinary Partnership to Introduce Groundbreaking Stem Cell Therapy for Pets#United_States#San_Diego#Stem_Cell_Therapy#Gallant#MWI_Animal_Health
Innovative Veterinary Partnership to Introduce Groundbreaking Stem Cell Therapy for Pets
Gallant partners with MWI Animal Health to deliver cutting-edge stem cell treatments for pets, marking a milestone in veterinary medicine.
third-news.com
February 27, 2026 at 6:34 PM
newsen.bsky.social
The Cell Clinic Opens in Akasaka, Advancing Stem Cell Treatments with Genomic Analysis#Japan#Tokyo#Stem_Cell_Therapy#Akasaka#genomic_analysis
The Cell Clinic Opens in Akasaka, Advancing Stem Cell Treatments with Genomic Analysis
Located in Akasaka, The Cell Clinic offers tailored stem cell therapies enhanced by genomic analysis, ensuring patient safety and care.
third-news.com
February 25, 2026 at 4:23 AM
newsen.bsky.social
The Growing Stem Cell Therapy Market: Projected to Reach USD 45.2 Billion by 2036#USA#Newark#regenerative_medicine#Stem_Cell_Therapy#mesenchymal_cells
The Growing Stem Cell Therapy Market: Projected to Reach USD 45.2 Billion by 2036
The global stem cell therapy market, valued at USD 18.7 billion in 2025, is expected to escalate to USD 45.2 billion by 2036, highlighting significant growth in regenerative medicine.
third-news.com
February 18, 2026 at 4:43 PM
newsen.bsky.social
TAM Global's Study Reforms Understanding of Mesenchymal Stem Cells#United_States#Nashville#Stem_Cell_Therapy#TAM_Global#MSC_treatments
TAM Global's Study Reforms Understanding of Mesenchymal Stem Cells
TAM Global's latest study sheds light on mesenchymal stem cell therapies, offering a scientific framework to evaluate their clinical efficacy.
third-news.com
January 8, 2026 at 1:24 PM
newsen.bsky.social
Unprecedented Growth in Regenerative Medicine Market Expected to Hit USD 403.86 Billion by 2032#USA#Austin#gene_therapy#regenerative_medicine#Stem_Cell_Therapy
Unprecedented Growth in Regenerative Medicine Market Expected to Hit USD 403.86 Billion by 2032
The regenerative medicine market is projected to grow from USD 48.45 billion in 2024 to an astonishing USD 403.86 billion by 2032, spurred by innovative therapies, rising chronic disease prevalence, and significant investments in biotechnology.
third-news.com
November 24, 2025 at 3:05 PM
newsen.bsky.social
Top U.S. Stem-Cell Clinic Takes on Celebrity Trends with Safe Alternatives at Home#United_States#Innovations#Dallas#Stem_Cell_Therapy#Medical_Center
Top U.S. Stem-Cell Clinic Takes on Celebrity Trends with Safe Alternatives at Home
As celebrities turn to unregulated stem-cell treatments abroad, Innovations Stem Cell Center offers safe, approved, and affordable options in the U.S.
third-news.com
November 6, 2025 at 4:52 PM
newsen.bsky.social
Innovations Stem Cell Center: The Leading Company for Stem Cell Therapy in 2025#USA#Dallas#regenerative_medicine#Stem_Cell_Therapy#Innovations_Stem_Cell_Center
Innovations Stem Cell Center: The Leading Company for Stem Cell Therapy in 2025
Innovations Stem Cell Center has been recognized as the leading provider of stem cell treatments in 2025, showcasing excellence in regenerative medicine.
third-news.com
October 23, 2025 at 10:23 PM
newsen.bsky.social
Innovations Stem Cell Center Recognized as Leader in Stem Cell Therapy for 2025#USA#Dallas#regenerative_medicine#Stem_Cell_Therapy#Innovations_Stem_Cell_Center
Innovations Stem Cell Center Recognized as Leader in Stem Cell Therapy for 2025
Innovations Stem Cell Center has been named the top company for stem cell therapy treatments in 2025 by Life Sciences Review, showcasing excellence in regenerative healthcare.
third-news.com
October 22, 2025 at 11:06 PM
newsen.bsky.social
Innovations Stem Cell Center Recognized as Top Provider of Stem Cell Therapy for 2025#United_States#Dallas#regenerative_medicine#Stem_Cell_Therapy#Innovations_Stem_Cell_Center
Innovations Stem Cell Center Recognized as Top Provider of Stem Cell Therapy for 2025
Innovations Stem Cell Center has been awarded the title of Top Stem Cell Therapy Treatments Company 2025, showcasing its leadership in regenerative medicine and patient care.
third-news.com
October 22, 2025 at 10:11 PM
newsen.bsky.social
Visionary Holdings and Yike Form Joint Venture to Advance Stem Cell Therapy for Diabetes Remission#Canada#Toronto#Stem_Cell_Therapy#Visionary_Holdings#Yike_Regenerative_Medicine
Visionary Holdings and Yike Form Joint Venture to Advance Stem Cell Therapy for Diabetes Remission
Visionary Holdings has partnered with Jiangsu Yike to launch a Toronto-based joint venture focused on stem cell therapy for diabetes, targeting a massive market opportunity.
third-news.com
October 22, 2025 at 2:27 PM
newsen.bsky.social
Breakthrough in Parkinson's Disease Treatment: Cell Therapy Shows Efficacy and Safety#USA#Honolulu#Parkinson's_Disease#Stem_Cell_Therapy#dopaminergic_neurons
Breakthrough in Parkinson's Disease Treatment: Cell Therapy Shows Efficacy and Safety
Recent studies on dopaminergic cell transplantation reveal promising results in enhancing motor functions and ensuring safety for Parkinson's patients. Discover the potential of this groundbreaking therapy.
third-news.com
October 5, 2025 at 6:11 PM
newsen.bsky.social
Gallant Pioneers New Veterinary Stem Cell Therapy with FDA Approval Milestone#USA#San_Diego#Veterinary_Medicine#Stem_Cell_Therapy#Gallant
Gallant Pioneers New Veterinary Stem Cell Therapy with FDA Approval Milestone
Gallant reaches a major milestone with FDA's confirmation of their first stem cell therapy's viability for treating feline conditions, aiming for approval in 2026.
third-news.com
September 23, 2025 at 1:22 PM
newsen.bsky.social
Olav Hellebø Takes Helm as Chairman of Blue Cell Therapeutics#Denmark#Copenhagen#Stem_Cell_Therapy#Blue_Cell_Therapeutics#Olav_Hellebø
Olav Hellebø Takes Helm as Chairman of Blue Cell Therapeutics
Blue Cell Therapeutics has appointed Olav Hellebø as Chairman of the Board. With extensive experience in pharma and biotech, his leadership is set to advance innovative stem cell treatments.
third-news.com
September 4, 2025 at 7:45 AM
newsen.bsky.social
Exploring the Rapid Growth of the Regenerative Medicine Market by 2032#USA#gene_therapy#regenerative_medicine#Westford#Stem_Cell_Therapy
Exploring the Rapid Growth of the Regenerative Medicine Market by 2032
The regenerative medicine market is set to grow significantly by 2032, driven by advancements in technology and chronic disease prevalence.
third-news.com
September 1, 2025 at 3:06 PM
newsen.bsky.social
Neuronata-R® Stem Cell Therapy: A Hopeful Breakthrough for ALS Patients Seeking FDA Approval#South_Korea#Seoul#ALS#Stem_Cell_Therapy#Neuronata-R
Neuronata-R® Stem Cell Therapy: A Hopeful Breakthrough for ALS Patients Seeking FDA Approval
Neuronata-R®, a stem cell therapy for ALS, shows significant efficacy in patients. The findings support a path toward FDA accelerated approval, promising new hope.
third-news.com
May 29, 2025 at 12:20 PM
newsen.bsky.social
CPC Corporation to Exhibit at the 98th Annual Meeting of Japanese Orthopaedic Association#Japan#Tokyo#Stem_Cell_Therapy#CPC_Corporation#Tops_Cells
CPC Corporation to Exhibit at the 98th Annual Meeting of Japanese Orthopaedic Association
CPC Corporation will showcase stem cell treatment insights at the 98th Annual Meeting of JOA from May 22 to May 25, 2025, at Tokyo.
third-news.com
May 19, 2025 at 3:51 AM
newsen.bsky.social
Gallant Appoints Dr. Rebecca Windsor to Enhance Veterinary Engagement for Upcoming Stem Cell Therapy for Cats#USA#San_Diego#Stem_Cell_Therapy#Gallant#Dr._Windsor
Gallant Appoints Dr. Rebecca Windsor to Enhance Veterinary Engagement for Upcoming Stem Cell Therapy for Cats
Gallant has appointed Dr. Rebecca Windsor as Director of Veterinary Affairs. Her role will enhance veterinary education as the company prepares its stem cell therapy for approval.
third-news.com
May 13, 2025 at 1:17 PM